Middle East & Africa Antimicrobial Surgical Suture Market Report by Scope, Segmentation, Dynamics, and Competitive Analysis

The Middle East & Africa antimicrobial surgical suture market size is expected to reach US$ 18.07 million by 2031 from US$ 10.80 million in 2023. The market is estimated to record a CAGR of 6.7% from 2024-2031.

Executive Summary and Middle East & Africa Antimicrobial Surgical Suture Market Analysis:

The UAE, Saudi Arabia, and South Africa are the three major countries in the Middle East and Southern Africa. Saudi Arabia was this region's largest antimicrobial surgical suture market in 2023. The market for antimicrobial surgical sutures in the Middle East & Africa is anticipated to register a CAGR of 6.7% during the forecast period. Factors such as the increasing number of plastic surgeries, the growing prevalence of cervical cancer, and the rising surgical treatments for diseases are driving the Middle East & Africa antimicrobial surgical suture market .

Middle East & Africa Antimicrobial Surgical Suture Market Segmentation Analysis:

Key segments that contributed to the derivation of the antimicrobial surgical suture market analysis are type, raw materials, application, and end user.

Based on type, the Middle East & Africa antimicrobial surgical suture market is bifurcated into triclosan antimicrobial suture and chlorhexidine antimicrobial suture. The triclosan antimicrobial suture held a larger share of the market in 2023.

By raw materials, the Middle East & Africa antimicrobial surgical suture market is segmented into polyglactin 910 antimicrobial suture, poliglecaprone 25, and polyglycolic acid. The polyglactin 910 antimicrobial suture segment held the largest share of the market in 2023.

By application, the Middle East & Africa antimicrobial surgical suture market is segmented into cardiovascular surgery, general surgery, ophthalmic surgery, gynaecological surgery, orthopedic surgery, plastic surgery, veterinary surgery, dental surgery, and others. The cardiovascular surgery segment held the largest share of the market in 2023.

By end user, the Middle East & Africa antimicrobial surgical suture market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the market in 2023.

Middle East & Africa Antimicrobial Surgical Suture Market Outlook

Antimicrobial surgical suture holds tremendous potential in the surgical treatments of various ailments owing to their ability to prevent surgical site infections, which are common and one of the common causes of morbidity in postoperative setups. A few of the recent strategic initiatives by antimicrobial surgical suture market players are mentioned below.

In July 2022, Dolphin Sutures launched its Antibacterials range of antibacterial sutures containing Triclosan coating, which is a known broad-spectrum antibacterial and antifungal agent. In May 2022, Ethicon, Inc., a Johnson & Johnson Company, filed 510(K) to receive premarket approval for PDS Plus Antibacterial (Polydioxanone) Sterile Synthetic Absorbable Surgical Suture. Thus, continuous advancements in surgical sutures with product developments, innovations, product launches, product approvals, mergers, acquisitions, and partnerships are expected to present significant growth opportunities in the antimicrobial surgical suture market growth in the coming years.

Middle East & Africa Antimicrobial Surgical Suture Market Country Insights

Based on country, the Middle East & Africa antimicrobial surgical suture market comprises Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia held the largest share in 2023.

Government support for the healthcare industry has been a significant driver, with initiatives such as the Saudi Vision 2030 prioritizing investments in healthcare infrastructure and innovative medical technologies, including antimicrobial sutures. Technological advancements have also played a crucial role in the market growth, with the adoption of advanced suture materials and technologies, such as triclosan-coated sutures. The increasing incidence of surgical site infections (SSIs) and antibiotic-resistant bacteria in Saudi healthcare settings has fueled the demand for effective infection prevention solutions such as antimicrobial sutures. The Saudi Ministry of Health's guidelines and recommendations for infection control and prevention have emphasized the importance of antimicrobial sutures, driving their adoption among healthcare providers. The country's growing healthcare sector, driven by a large and aging population and increasing healthcare expenditure, has also contributed to the growth of the antimicrobial surgical sutures market in Saudi Arabia.

Middle East & Africa Antimicrobial Surgical Suture Market Company Profiles

Some of the key players operating in the market include Advanced MedTech Solutions Pvt. Ltd.; Boz Medical; Futura Surgicare Pvt Ltd (Dolphin Sutures); Healthium Medtech Limited; Internacional Farmacéutica SA; Johnson & Johnson; Meril Life Sciences Pvt Ltd; and TI Medical among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

Middle East & Africa Antimicrobial Surgical Suture Market Research Methodology:

The following methodology has been followed for the collection and analysis of data presented in this report.

Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

Company websites, annual reports, financial statements, broker analyses, and investor presentations. Industry trade journals and other relevant publications. Government documents, statistical databases, and market reports. News articles, press releases, and webcasts specific to companies operating in the market. Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.

Primary Research

The publisher conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:

Validate and refine findings from secondary research. Enhance the expertise and market understanding of the analysis team. Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects. Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East & Africa antimicrobial surgical suture market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa antimicrobial surgical suture market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the antimicrobial surgical suture market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.